Phase II Trial Opens: Metformin Plus Remote Cognitive Monitoring vs Standard Care in Brain Tumour Patients Post-Cranial Radiation — What Clinicians Need to Know

References

1. 1.Mayo Clinic. (2024). Neuro-Oncology Anywhere: Deploying Mayo Clinic's Remote Cognitive Assessment Battery and Wearable Device Monitoring Platform While Assessing the Impact of Metformin on Cognition and Quality of Life in Patients With History of Cranial Radiation (NCT06377696). ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT06377696
2. 2.Gondi, V., Pugh, S. L., Tome, W. A., Caine, C., Corn, B., Kanner, A., Rowley, H., Kundapur, V., DeNittis, A., Greenspoon, J. N., Konski, A. A., Bauman, G. S., Shah, S., Shi, W., Wendland, M., Kachnic, L., & Mehta, M. P. (2014). Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): A phase II multi-institutional trial. Journal of Clinical Oncology, 32(34), 3810–3816. https://doi.org/10.1200/JCO.2014.57.2909
3. 3.Łabuzek, K., Suchy, D., Gabryel, B., Bielecka, A., Liber, S., & Okopień, B. (2010). Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide. Pharmacological Reports, 62(5), 956–965. https://doi.org/10.1016/S1734-1140(10)70300-7
4. 4.Gehring, K., Aaronson, N. K., Taphoorn, M. J. B., & Sitskoorn, M. M. (2011). Interventions for cognitive deficits in patients with a brain tumor: An update. Expert Review of Anticancer Therapy, 11(11), 1779–1795. https://doi.org/10.1586/era.11.82
5. 5.Wefel, J. S., Kesler, S. R., Noll, K. R., & Schagen, S. B. (2015). Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA: A Cancer Journal for Clinicians, 65(2), 123–138. https://doi.org/10.3322/caac.21258
6. 6.Brown, P. D., Gondi, V., Pugh, S., Tome, W. A., Wefel, J. S., Armstrong, T. S., Bovi, J. A., Robinson, C., Konski, A., Khuntia, D., Grosshans, D., Benzinger, T. L. S., Bruner, D., Gilbert, M. R., Roberge, D., Kundapur, V., Devisetty, K., Shah, S., Usuki, K., … Mehta, M. P. (2020). Hippocampal avoidance during whole-brain radiotherapy plus memantine for 1–3 brain metastases: Phase III trial NRG Oncology CC001. Journal of Clinical Oncology, 38(10), 1019–1029. https://doi.org/10.1200/JCO.19.02767